6 Southeast Asian Markets · Local Teams & Joint Ventures Direct Delivery · Registrations Held by the Manufacturer

Southeast Asia Medical Device Regulatory Access · One-stop Consulting

Indonesia / Vietnam / Malaysia / Philippines / Thailand / SingaporeMedical Device Registration

Direct delivery by local teams and joint ventures in all six markets — from product classification, dossier submission and approval to post-market compliance — an efficient, predictable and stable SEA market-access solution.

Registrations held by the manufacturer6 local entities · verifiable credentialsNative-language project managementFree initial assessment
0+
Companies Served
Spanning imaging, monitoring, orthopaedic implants, dental, ophthalmology, AI software and more
0+
Local Experts
Local teams & joint ventures in six markets, native-level liaison
0%
Faster Approval Cycles
About 40% faster than typical market timelines
0
Registration Cases
90%+ are medical devices, verifiable in official databases

Why ZANFORA

Local Entities · Predictable Delivery

We maintain local teams, resident staff and joint ventures in all six Southeast Asian markets, with registrations held by the manufacturer — helping you keep control of your market position.

🏢

Direct Presence in 6 Markets

Local teams, resident staff and joint ventures manage the entire registration process. Registrations are held by the manufacturer — no distributor lock-in.

⚡

Review-risk Anticipation

We know the deficiency-letter habits of BPOM, MOH, MDA, PFDA, TFDA and HSA, reducing review rounds and cutting approval time by about 40% versus market averages.

🤝

Zero Time-zone, Native-language Liaison

Our China team connects directly with local experts in six markets: Chinese-language project management, local delivery, zero language barrier, zero time difference, real-time updates at key milestones.

🧭

NMPA-plus-SEA Portfolio Strategy

Use your NMPA registration as the reference-country approval to chain market access across six SEA markets, reusing ASEAN CSDT dossiers with multi-market submissions to Malaysia, Thailand and Singapore.

Services

A Two-dimensional Service Matrix

Browse each market's requirements and latest regulatory updates by country, or explore by service line.

Indonesia

Ministry of Health (Kemenkes) / BPOM

With 280 million people, Indonesia is ASEAN's largest single market. Medical devices and IVD are registered with the Ministry of Health (Kemenkes) under risk classes A–D; BPOM handles certain disinfectant/combination products; and from 2026, halal certification is being phased in for devices containing animal-derived materials.

View access details & regulatory updates →

Vietnam

Ministry of Health (MOH) — Department of Medical Equipment (DME)

Vietnam uses an A–D classification with 5-year registration validity. Registration fees are being cut by 50% in phases in 2026, and Decree 37/2026 updates labelling requirements. The Class A/B self-declaration route is extremely fast, making Vietnam a classic quick-turnaround market.

View access details & regulatory updates →

Malaysia

Medical Device Authority (MDA)

Malaysia regulates under Act 737; Class B/C/D registrations require CAB conformity assessment. Full registration mutual recognition is in place with Thailand's TFDA and Singapore's HSA — reference-country approvals unlock verification routes, making Malaysia the core hub for multi-market ASEAN submissions.

View access details & regulatory updates →

Philippines

Food and Drug Administration (PFDA, CDRRHR)

The Philippines manages devices under RA 9711 and AO 2018-0002 (aligned with the AMDD) via CMDN/CMDR, with registration fees currently suspended in phases. Foreign manufacturers must appoint a Local Authorized Representative (LAR) and rely on LTO-licensed importers for distribution.

View access details & regulatory updates →

Thailand

Thai FDA

Thailand applies the AMDD four-class system with three routes: Class A Notification, Class B Listing and Class C/D Registration. The 2026 electronic change system is live and Malaysia mutual recognition is fully in force — overall access certainty is high.

View access details & regulatory updates →

Singapore

Health Sciences Authority (HSA)

Singapore is ASEAN's most mature and international regulatory hub market. HSA manages Classes A–D and offers Immediate/Abridged/Full/Expedited evaluation routes based on reference-country approvals; registrations remain valid long term with annual renewal.

View access details & regulatory updates →
Core Service
📋

Medical Device Registration

  • NMPA + SEA access: combined submissions for China approval and six-market registration
  • End-to-end registration with Indonesia MOH/BPOM, Vietnam MOH, Malaysia MDA, Philippines PFDA, Thailand TFDA and Singapore HSA
  • IVD registration: dedicated line for clinical chemistry, immunoassay and molecular diagnostics
  • ASEAN CSDT dossier preparation · reference-country routes · local authorized representative / licence holder services
🏅

QMS Coaching

  • ISO 13485 QMS establishment and certification coaching
  • MDSAP single-audit program (5 countries) coaching
  • Local BGMP / GDPMD distribution & manufacturing compliance coaching and audit preparation
✈️

Value-added Services

  • FSC (Free Sale Certificate) application
  • Apostille and consular legalization
  • Professional translation: Thai, Vietnamese, Indonesian, Malay, English
  • Representative services: local authorized representative / registration holder / importer liaison
🔍

Access Strategy Assessment

  • Product classification and route planning (report within 1 week)
  • Multi-market submission and mutual-recognition route modeling
  • Timeline & budget planning and risk assessment

Case Studies

Six Markets, Proven Track Record

179 registration cases, over 90% medical devices, verifiable in the official databases of each regulator.

IndonesiaIVD

Clinical Chemistry Reagents (Class B)

  • Local NameReagen kimia klinik(Clinical Chemistry Reagents)
  • Registration RouteKemenkes registration (Class B standard route)
  • Timeline1 month
  • Case HighlightsChina NMPA registration used as reference-country approval, significantly faster technical review
VietnamIVD

Clinical Chemistry Reagents (Class B)

  • Local NameReagent hóa sinh(Clinical Chemistry Reagents)
  • Registration RouteMOH express lane (NMPA reference route)
  • Timeline10 days
  • Case HighlightsNMPA registration used as reference-country approval — fast DME clearance
MalaysiaIVD

Chemiluminescence Immunoassay Reagents(CLIA) (Class C)

  • Local NameChemiluminescence Immunoassay Reagents(CLIA)
  • Registration RouteMDA registration (CAB assessment)
  • Timeline3 month
  • Case HighlightsSingapore HSA registration via the mutual-recognition verification route — review in ~30 working days
PhilippinesIVD

Rapid Diagnostic Test Kit (Class B)

  • Local NameRapid Diagnostic Test Kit
  • Registration RouteCMDR (abbreviated review channel)
  • Timeline6 month
  • Case HighlightsChina NMPA registration as reference-country approval speeds up CMDR review
ThailandIVD

HbA1c Assay Kit (Class C)

  • Local Nameชุดตรวจ HbA1c(HbA1c Assay Kit)
  • Registration RouteTFDA registration (NMPA reference route)
  • Timeline6 month
  • Case HighlightsChina NMPA registration as reference-country approval speeds up TFDA review
SingaporeIVD

Autoimmune Antibody Assay Kit (Class C)

  • Local NameAutoimmune Antibody Assay Kit
  • Registration RouteHSA Abridged evaluation (FDA/CE references)
  • Timeline~ 180 working days
  • Case HighlightsFDA 510(k) approval via the Abridged route — a controllable timeline

Regulatory News

SEA Regulatory Updates, One Step Ahead

180 regulatory updates sorted by official publication date, each with a link to the official source.

Market Surveillance

FDA Advisory No.2026-1116: Public Health Warning on Unregistered Devices

A warning issued for unregistered suture needles and other products — verify registration status.

Standards Update

Thailand Updates Mandatory Device Standards: 21 Product Categories Added

Companies should verify the standards versions cited for their products.

Accelerated Review

Changes Already Approved by FDA/CE: Approval in as Fast as 15 Working Days

Reference-approved changes use the fast lane, significantly shortening post-market change cycles.

Fees & Charges

Indonesia Ministry of Health (Kemenkes) Publishes Annual Fee & Charge Schedule Adjustment

Registration, evaluation and annual maintenance fees updated — adjust budgets accordingly.

Enforcement Report

MDA Publishes Results of Enforcement Against Unregistered Devices

Sweeps covered offline and e-commerce channels; purchasers should verify MDA registration numbers.

Fees & Charges

Vietnam Ministry of Health (MOH) Publishes Annual Fee & Charge Schedule Adjustment

Registration, evaluation and annual maintenance fees updated — adjust budgets accordingly.

Frequently asked questions

Clarify the key questions before your access assessment

General regulatory information only. The applicable pathway depends on your product and current local requirements.

Which products can start with a Southeast Asia access assessment?

Active and non-active medical devices, IVDs and SaMD can be assessed. Provide intended use, technical features, existing certificates and target markets so classification, pathway and documentation gaps can be reviewed.

Can I apply without NMPA, CE or FDA approval?

It depends on the target market, device class and reference-country requirements. Some pathways require prior approval while others accept a complete technical submission. Current local rules and authority guidance always prevail.

How are registration ownership and local representation handled?

The plan is designed to protect the manufacturer's registration interests. Certificate holding, authorised representation and importer arrangements are confirmed in writing before submission to reduce later change-of-holder risks.

How can multi-market submissions reduce duplicated work?

A CSDT-based dossier can support reuse, alongside reference approvals, local classification and labelling requirements. Reusable content must be checked market by market; reuse does not automatically mean mutual recognition.

Contact Us

Start Your SEA Market Access Journey

A senior consultant will contact you within 1 business day with a free initial access assessment.

💬Live Chat